| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | A human recombinant partial protein (amino acids M1-Q106) was used as the immunogen for the GLRX antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
GLRX Antibody / Glutaredoxin 1 is a anti-GLRX Rabbit antibody Polyclonal (rabbit origin) supplied in Antigen affinity purified format. Recommended for workflows such as Western blot (WB), IHC-P, Flow cytometry (FACS), Immunofluorescence (IF), ELISA with listed reactivity in Human. Reported localization: Cytoplasmic.
Key elements and design rationale
- Target: GLRX
- Antibody details: Rabbit, Polyclonal (rabbit origin), isotype Rabbit IgG
- Format: Antigen affinity purified
- Applications (as listed): WB, IHC-P, FACS, IF, ELISA
Biological background
GLRX is widely expressed in mammalian tissues, with particularly high levels in heart, liver, and skeletal muscle. Its enzymatic activity is critical in pathways that counteract oxidative damage and maintain the thiol status of proteins. Dysregulation of GLRX has been linked to cardiovascular disease, neurodegenerative disorders, and cancer, where imbalances in redox signaling contribute to disease pathology. Employing a GLRX antibody allows scientists to analyze protein expression, localization, and post-translational modifications in health and disease.
In addition to its protective role, GLRX has been implicated in apoptosis, inflammatory responses, and mitochondrial function. It also interacts with iron-sulfur cluster proteins, influencing mitochondrial biogenesis and energy metabolism. Because oxidative stress is a common hallmark of many diseases, GLRX remains an attractive target for translational research. Using a GLRX antibody provides a reliable approach for monitoring its activity and contribution to cellular redox control.
Research relevance and current trends
- Connecting protein-level changes to phenotype using orthogonal readouts (genetic perturbation, transcriptomics, imaging).
- Considering isoforms and post-translational regulation when interpreting protein-level changes.
- Comparing results across species and model systems with matched controls.
Common research applications
- Western blotting: compare relative abundance and activation-state changes across conditions.
- Immunofluorescence: visualize subcellular distribution and cell-to-cell heterogeneity.
- Immunohistochemistry: map target signal in tissue context and compare regions/phenotypes.
- Flow cytometry: quantify target-positive populations and signal shifts at single-cell resolution.
- ELISA: support antibody-based quantification in assay formats where applicable.
Interpret changes in signal alongside appropriate controls and, when relevant, in parallel with total-protein or pathway readouts.
Notes for experimental interpretation
- Signal can reflect expression level, isoform composition, and post-translational state; interpret results in the context of your model system and stimuli.
- Species differences and sample matrices can influence epitope recognition; prioritize matched controls and orthogonal confirmation when feasible.
Antibody notes: Polyclonal antibodies recognize multiple epitopes, which can broaden the epitope footprint and may increase sensitivity in some contexts.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
